Why the study?
Electronic blood pressure measurement devices require independent clinical validation in general and specific populations, prompting assessment of the Omron RS6 wrist device in obese Sudanese patients.
Does the Omron RS6 wrist blood pressure device provide valid measurements compared to a standard mercury sphygmomanometer in obese Sudanese patients?
Does the Omron RS6 wrist blood pressure device provide valid measurements compared to a standard mercury sphygmomanometer in obese Sudanese patients?
The Omron RS6 wrist blood pressure device is a valid tool for measuring blood pressure in obese patients according to ESH-IP2 criteria.
Answers are grounded in this paper and cite their sources.
May support wrist BP use in obese Sudanese patients; leaves open need for larger validation studies.
<ns3:p> <ns3:bold>Background:</ns3:bold> Electronic devices for measuring blood pressure (BP) need to go through independent clinical validation as recommended by different authorities, both in general and specific populations. The aim of this study was to assess the validity of the Omron RS6 (HEM-6221-E) wrist oscillometric devices in obese Sudanese patients. </ns3:p> <ns3:p> <ns3:bold>Methods:</ns3:bold> Of 90 obese individuals invited for recruitment, 33 were included in the study, and had their BP at the level of the wrist measured using Omron RS6 and standard mercury sphygmomanometer. Two observations were made and the mean was taken. BP differences between the two methods for the 33 participants were classified into three categories (≤5, ≤10, and ≤15 mmHg), according to the European Society of Hypertension-International Protocol revision 2010 (ESH-IP2) criteria. This was then used to assess the validity of the tested Omron RS6 device. </ns3:p> <ns3:p> <ns3:bold>Results:</ns3:bold> Participants had a mean age of 56.97 years (standard deviation (SD), 8.75; range, 36-79). Average systolic blood pressure (SBP) was 146.21 mmHg (SD, 23.07; range, 107-182), and average diastolic blood pressure (DBP) was 93.82 mmHg (SD, 16.06; range, 67-128). There was a good agreement between the two observations using the OMRON RS6 and the standard sphygmomanometer: −4 to + 3 mmHg for SBP and −4 to +4 mmHg for DBP, with the mean difference of 1.73±1.11 mmHg for SBP and 1.49±1.02 mmHg for DBP. </ns3:p> <ns3:p> <ns3:bold>Conclusion:</ns3:bold> Thus, the Omron RS6 (HEM-6221-E) is a valid and suitable measure of BP according to ESH-IP2. </ns3:p>
No takes yet. Share an insight, caveat, or question.
Ali et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: